Close Menu
Home » I-SPY 2 Graduates First Two Drugs for Breast Cancer

I-SPY 2 Graduates First Two Drugs for Breast Cancer

Dec 27, 2013
|
staff reporter

NEW YORK (GenomeWeb News) – The Foundation for the National Institutes of Health on Thursday announced that the I-SPY 2 Trial has graduated the first two drugs from its multidrug standing platform trial.

The two drugs are veliparib, developed by AbbVie, and neratinib, developed by Puma Biotechnology. Both are for breast cancer.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Scan

A 'Double Whammy'

The Guardian reports that the Mammalian Genetics Unit at the Harwell Institute is to close.

So Much Plastic

Scientific research itself contributes to plastic waste and isn't very sustainable, FiveThirtyEight reports.

With a Little Lemon?

Restaurants in the US may soon serve AquaBounty's genetically modified salmon, according to the Associated Press.

Science Has a Trio of Ruminant Genome Studies and More

In Science this week: three studies from the Ruminant Genome Project, and more.

Jun
25
Featured Webinar

Error-Corrected Sequencing to Detect Measurable Residual Disease in Post-Transplant MDS Cases

Sponsored by
Agilent
Jun
26
Featured Webinar

Genome-Wide Study Reveals a Novel Regulatory Pathway: Translation Affects mRNA Stability in a Codon-Dependent Manner

Sponsored by
Lexogen

This webinar will outline a study that combined genome-wide and classical molecular approaches to demonstrate that translation strongly affects mRNA stability in a codon-dependent manner, ultimately influencing mRNA and protein levels in higher organisms.

Jul
23
Featured Webinar

A Novel Quality Improvement Model to Support Molecular Testing of Oncology Patients

Sponsored by
Qiagen

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients. 

Jul
30
Featured Webinar

Single-Cell Sequencing Reveals Clonal Heterogeneity in Acute Lymphoblastic Leukemia

Sponsored by
Mission Bio

This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.

What's Popular?

In Cancer

  1. Liquid Biopsy Assay From MSKCC Approved by New York State

  2. AMP and CAP Comment on Palmetto Proposed Guidelines for NGS Testing of Myeloid Disorders

  3. Personalis Prices $154.9M IPO

  4. Liquid Biopsy Monitoring, Surveillance Efforts Accelerate Across Cancer Types and Technologies

    Premium

  5. Sweden's Saga Diagnostics Eyes Clinical Oncology Space With Ultrasensitive Mutation Detection Method

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.